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We generated both replication-incompetent (HAd5-gD-E1 and HAd5-tgD-E1) and replication-competent (HAd5-gD-E3 and
HAd5-tgD-E3) human adenovirus type 5 (HAd5) recombinants expressing the full (gD) or truncated form (tgD) of the glycopro-
tein gD gene of bovine herpevirus type 1 (BHV-1). Recombinant gD and tgD expressed by HAd5-gD-E1 and HAd5-gD-E3
and by HAd5-tgD-E1 and HAd5-tgD-E3, respectively, were recognized by gD-specific monoclonal antibodies (MAbs) directed
against linear and conformational epitopes, suggesting that antigenicity of recombinant gD and tgD was similar to that of
the native gD expressed in BHV-1 infected cells. In HAd5-gD-E1- or HAd5-gD-E3-inoculated cotton rats there was a strong
gD- and HAd5-specific IgG and IgA antibody response. The immune response was significantly lower in animals similarly
immunized with HAd5-tgD-E1 or HAd5-tgD-E3, indicating that live adenovirus vaccine vectors may be better suited to the
full-length form of glycoprotein gD than its truncated form. After a BHV-1 challenge, no infectious BHV-1 virions were
isolated from the trachea of cotton rats previously immunized with HAd5-gD-E1 or HAd5-gD-E3. These results suggest that
adenovirus E1 insertion (replication-incompetent) and E3 insertion (replication-competent) vectors have excellent potential
for use in developing live recombinant virus vaccines and provide evidence that the cotton rat model can be used in BHV-
1 vaccination–challenge trials. q 1996 Academic Press, Inc.
INTRODUCTION 1977), that constitutively expresses E1 proteins. How-
ever, complete replication is not required for the expres-
Adenovirus-based vectors have been demonstrated to
sion of foreign genes in E1 deleted viruses in cells whichbe excellent vehicles for expressing foreign genes in
do not provide complementary E1 functions (Alkhatib andmammalian cells (Graham, 1990; Graham and Prevec,
Briedis, 1988). In addition, immunization of experimental1992; Berkner, 1992; Mittal et al., 1994). The regions that
animals with recombinants containing genes insertedhave been used for inserting foreign genes include the
into the E1 region can induce a systemic immune re-early (E) region 1 (E1) and E3 (Berkner and Sharp, 1984;
sponse to the foreign gene product and provide protec-Haj-Ahmad and Graham, 1986). When the E3 region is
tion against subsequent challenge (Ragot et al., 1993a;used for inserting foreign genes, the replication-compe-
Fooks et al., 1995). Whether these recombinants can alsotent recombinants replicate to the same level as wild-
induce mucosal immunity remains to be determined.type (wt) adenovirus both in tissue culture (Johnson et
The cotton rat (Sigmodon hispidus) has been shownal., 1988; Chanda et al., 1990; Bett et al., 1993; Mittal et
to support the replication of both human adenovirus typeal., 1995a) and in experimental animals (Lubeck et al.,
5 (HAd5) (Pacini et al., 1984; Prince et al., 1993) and1989; Prevec et al., 1989, 1990; Mittal et al., 1993; Braciak
bovine herpesvirus type 1 (BHV-1) (X. P. Liang, personalet al., 1993; Breker-Klassen et al., 1995; Torres et al.,
communication; Papp et al., manuscript in preparation)1996). Since E1 gene products are indispensible for virus
by the intranasal route of inoculation, and thus it servesgrowth, replication-incompetent recombinants con-
as a useful animal model for both of these viruses. BHV-taining foreign genes in E1 can be produced only in a
1, a member of the alpha-herpesvirus subfamily, is acell line, such as Graham’s 293 cells (Graham et al.,
major pathogen of cattle involved in the development of
the complex respiratory disease syndrome called ‘‘ship-
1 This paper is published with the permission of the director of the ping fever,’’ which causes heavy economic losses to theVeterinary Infectious Disease Organization as Journal Series No. 212.
cattle industry (Yates, 1982). Since currently available2 To whom correspondence and reprint requests should be ad-
dressed. BHV-1 vaccines are either not very effective or not suit-
299
0042-6822/96 $18.00
Copyright q 1996 by Academic Press, Inc.
All rights of reproduction in any form reserved.
AID VY 8044 / 6a1b$$$521 07-16-96 20:27:17 vira AP: Virology
300 MITTAL ET AL.
able, particularly for pregnant animals, there is an urgent on Graham’s 293 human fetal kidney cells (Graham et
al., 1977) maintained as monolayer cultures in Eagle’sneed for a better vaccine for BHV-1.
The BHV-1 envelope contains a number of virus-en- minimum essential medium (MEM) (Life Technologies
Inc.) supplemented with 10% fetal bovine serum, 25 mMcoded glycoproteins. Although 10 glycoprotein genes
have been localized and sequenced in BHV-1, desig- HEPES, and 50 mg/ml gentamicin. For animal inoculation,
the viruses were purified by cesium chloride density-nated gB, gC, gD, gE, gG, gH, gI, gK, gL, and gM, only a
few have been characterized at the protein level (re- gradient centrifugation (Graham and Prevec, 1991). The
Cooper strain of BHV-1 was obtained from the Nationalviewed by Tikoo et al., 1995; Khadr et al., 1996; Khattar
et al., 1995, 1996; Vlcek et al., 1995). Glycoprotein gD, Veterinary Services Laboratories, Ames, Iowa, and was
expanded in Madin–Darby bovine kidney (MDBK) cellin particular, constitutes one of the major glycoproteins
which form the virus envelope and is essential for virus monolayers grown in MEM supplemented with 10% fetal
bovine serum, 25 mM HEPES, and 50 mg/ml gentamicin.replication (van Drunen Littel-van den Hurk and Babiuk,
1986; Tikoo et al., 1990; Fehler et al., 1992). In BHV-1- A cotton rat lung (CTRL) cell line (Breker-Klassen et al.,
1995) was also grown as monolayers in MEM supple-infected cells, gD, a 417-amino-acid protein (Tikoo et al.,
1990), undergoes both N-linked and O-linked glycosyla- mented with 10% fetal bovine serum, 25 mM HEPES, and
50 mg/ml gentamicin.tion to result in a mature glycoprotein of 71 kDa (van
Drunen Littel-van den Hurk et al., 1986; Tikoo et al.,
Animals1993a).
Purified preparations of either authentic gD (Babiuk et
An inbred colony of cotton rats (Sigmodon hispidus)
al., 1987; van Drunen Littel-van den Hurk et al., 1990) or
maintained at the Veterinary Infectious Disease Organi-
recombinant gD (van Drunen Littel-van den Hurk et al.,
zation, Saskatoon (Mittal et al., 1995b), was the source
1993) alone can protect cattle from disease, suggesting
of animals for this study.
that gD may be a potent candidate for an effective recom-
binant vaccine. Furthermore, a truncated-form of gD (tgD) Generation of HAd5 recombinants
(Tikoo et al., 1993b) can be produced in high quantities
using a heat-shock promoter system in stably transfected The 1.1-kb BglII–XbaI fragment containing the BHV-1
tgD gene was isolated from plasmid pSKTgIVZ, whichmammalian cells (Kowalski et al., 1993), and animals
immunized with tgD are protected from BHV-1 challenge was created by putting the NcoI site at the initiation
codon for gD and the XbaI site after a three-phase stop(van Drunen Littel-van den Hurk et al., 1994). Unfortu-
nately, immunization of calves with gD or tgD does not codon at amino acid residue 355 of gD using plasmid
gIVd1 (Tikoo et al., 1993b). The fragment was insertedelicit lifelong immunity; therefore, there is a need for bet-
ter delivery or formulation systems to enhance the dura- into an E1 transfer plasmid, pAdBM5 (B. Massie, unpub-
lished results), which was derived from pAdBM1 (Lamar-tion of immunity and more importantly to induce immunity
at the mucosal surface, the site of virus entry. che et al., 1990) at the BamHI site by blunt end ligation
to create pAdBM5-tgD containing the tgD gene in the E1The present report compares the usefulness of replica-
tion-incompetent (E1 insertion) and replication-compe- antiparallel orientation. The dlE1E3 genome and
pAdBM5-tgD were cleaved with ClaI and this DNA wastent (E3 insertion) HAd5 vectors expressing the full or
truncated form of the BHV-1 gD gene in eliciting gD- and used to cotransfect 293 cells by the calcium phosphate
technique (Graham and van der Eb, 1973). Virus plaquesHAd5-specific systemic and mucosal immune responses
in the cotton rat model. Furthermore, these studies indi- that originated following cotransfection of Graham’s 293
cells were expanded and the presence of the tgD genecate that the form of antigen (truncated versus full-length)
can influence the magnitude of the immune response, in the HAd5-tgD-E1 recombinant was identified by re-
striction enzyme digestion and further confirmed byindicating that antigen presentation also needs to be
considered when designing vaccine strategies. Southern blot hybridization (Sambrook et al., 1989). Simi-
larly, the full-length BHV-1 gD gene was also inserted
into the E1 region of the dlE1E3 genome to generateMATERIALS AND METHODS
HAd5-gD-E1, the construction of which has been de-
Viruses and cell culture
scribed elsewhere (van Drunen Littel-van den Hurk et
al., 1993).The wt HAd5 was obtained from Dr. F. L. Graham,
Departments of Biology and Pathology, McMaster Uni- The BHV-1 gD and tgD genes were also introduced
into the E3 region of the HAd5 genome following a strat-versity, Hamilton, Ontario. The dlE1E3 virus, derived from
wt HAd5 by introducing deletions in both the E1 and E3 egy described previously (Mittal et al., 1993). Initially, a
1.6-kb XbaI fragment containing the SV40 promoter, theregions (Gluzman et al., 1982), was obtained from Dr. B.
Massie, Biotechnology Research Institute, National Re- cloning linker, the SV40 polyadenylation signal, and am-
picillin-resistance (ampr) gene was obtained fromsearch Council of Canada, Montreal, Quebec. The wt
and HAd5 recombinant viruses were grown and titrated pSV2X11 (Mittal et al., 1993) and was inserted into the
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XbaI site of pFG144K5 (Mittal et al., 1993) in the E3 paral- each group were intranasally challenged with 50 ml BHV-
1 (107 PFU/animal) at 6 weeks following primary inocula-lel orientation to produce pFG144K5-SV-ampr. The ampr
gene was excised by digestion with XhoI to obtain tion and killed by an overdose of halothane at 42 hr
postchallenge, and the trachea and lung were collectedpFG144K5-SV. The 1.3-kb BglII fragment containing the
gD gene was isolated from plasmid pRSV1.3 (Tikoo et for virus isolation.
al., 1993b) and cloned into the BamHI site of pFGG144K5-
ELISASV to produce pFG144K5-SV-gD containing the gD gene
downstream of the SV40 promoter in the E3 parallel ori- The serum samples and the lung and nasal washes
entation. Similarly the tgD gene was isolated from plas- collected from cotton rats were used to detect BHV-1 gD-
mid pSKTgIVZ and inserted into pFG144K5-SV at the specific and HAd5-specific IgG and IgA antibodies by
BamHI site by blunt-end ligation to construct pFG144K5- ELISA as previously described (van Drunen Littel-van den
SV-tgD containing the tgD gene downstream of the SV40 Hurk et al., 1984; Mittal et al., 1995b). Ninety-six-well
promoter in the E3 parallel orientation. Plasmids microtiter plates were coated with either purified gD or
pFG144K5-SV, pFG144K5-SV-gD or pFG144K5-SV-tgD, HAd5 and incubated with different dilutions of each sam-
and pFG173 (Mittal et al., 1993) were used to cotransfect ple. A horseradish peroxidase (HRP)-conjugated goat
293 cells by the calcium phosphate technique to gener- anti-rat IgG serum (Zymed) was used as a secondary
ate dlE3, HAd5-gD-E3, and HAd5-tgD-E3, respectively, by antibody to detect IgG antibodies, whereas a polyclonal
intracellular recombination. The resultant viruses were rabbit anti-rat IgA (obtained as a gift from Dr. B. Under-
grown on Graham’s 293 cells and the presence of the down, Department of Pathology, McMaster University,
proper insert was identified by restriction enzyme diges- Hamilton, Canada) and HRP-conjugated goat anti-rabbit
tion. Each virus was plaque purified twice before further IgG (Boehringer-Mannheim) sera were used to detect
characterization. IgA antibodies. The optical density (OD) at 405 nm repre-
sents the mean for three to six animals { SD.
Radiolabeling of proteins and immunoprecipitation
Virus neutralization assaysImmunoprecipitation of 35S-labeled virus-infected cell
extracts was performed essentially as described pre- BHV-1 and HAd5 neutralization assays were carried
viously (Mittal et al., 1993). Briefly, mock- or virus-infected out as described previously (van Drunen Littel-van den
cells were labeled with [35S]methionine (DuPont Canada, Hurk et al., 1984; Mittal et al., 1993). The highest recipro-
Inc.), and the supernatant and the cell pellet were sepa- cal serum dilution resulting in reduction of virus plaque
rately subjected to immunoprecipitation using a panel of formation by at least 50% was considered the virus neu-
gD-specific monoclonal antibodies (MAbs) (van Drunen tralizing antibody titer.
Littel-van den Hurk et al., 1984; Hughes et al., 1988). The
immunoprecipitated proteins were analyzed by sodium Virus isolation
dodecyl sulfate–polyacrylamide gel electrophoresis
The trachea and lungs of virus-challenged cotton rats
(SDS–PAGE).
were separately homogenized in 1 ml MEM and the su-
pernatants were used for BHV-1 titration on MDBK cellsAnimal inoculation
by plaque assays (Rouse and Babiuk, 1974).
Forty-two 4- to 6-week-old cotton rats were randomly
grouped into seven groups (six animals/group), and six RESULTS
groups were inoculated twice, at Day 0 and Day 21 by
Generation of HAd5 recombinants
intradermal and intranasal routes, respectively, with 50
ml of a purified preparation containing 107 PFU of dlE1E3, To compare the usefulness of replication-incompetent
(E1 insertion vectors) and replication-competent (E3 in-HAd5-gD-E1, HAd5-tgD-E1, dlE3, HAd5-gD-E3, or HAd5-
tgD-E3. The control group was similarly inoculated with sertion vectors) HAd5 recombinants as delivery vehicles
for live recombinant virus vaccines, and to evaluate the0.1 M phosphate-buffered saline (PBS), pH 7.2. The blood
samples were collected at 0, 3, and 6 weeks after primary role of gD and tgD proteins of BHV-1 as vaccine antigens
when delivered by viral vectors, a number of HAd5 re-inoculation to examine the development of BHV-1-gD-
specific and HAd5-specific antibodies by enzyme-linked combinants were constructed (Table 1). The gD and tgD
genes were introduced into the E1 region of HAd5 in theimmunosorbent assays (ELISA) and virus neutralization
assays. Three animals of each group were euthanized E1 antiparallel orientation. The choice of using the major
late promoter (MLP)-based complex regulatory elementat 6 weeks after primary inoculation by an overdose of
halothane and the lung and nasal secretions were col- and multiple polyadenylation signals was based on the
observation that high levels of foreign gene expressionlected separately to monitor the development of BHV-
1-gD-specific and HAd5-specific mucosal IgG and IgA by HAd5 E1 insertion vectors could be obtained by these
regulatory sequences (Lamarche et al., 1990).antibodies by ELISA. The remaining three animals of
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TABLE 1
HAd5 Recombinants Used in This Study
Regulatory sequences
Foreign HAd5 Foreign gene Polyadenylation
Virus insert deletiona insertion into Promoter signal
HAd5-gD-E1 BHV-1 gD E1 and E3 E1 MLP Multiple
HAd5-tgD-E1 BHV-1 tgD E1 and E3 E1 MLP Multiple
HAd5-gD-E3 BHV-1 gD E3 E3 SV40 SV40
HAd5-tgD-E3 BHV-1 tgD E3 E3 SV40 SV40
dlE3 — E3 b SV40 SV40
a E1 deletion: 3-kb ClaI deletion between m.u. 1 and 9.4. E3 deletion: 1.9-kb XbaI deletion between m.u. 79.6 and 84.85.
b The E3 deletion in dlE3 was replaced with the SV40 promoter and polyadenylation sequences.
Since our previous observation suggested that the representing the transmembrane anchor domain and the
cytoplasmic domain (Tikoo et al., 1993b), the tgD proteinSV40 early promoter and polyadenylation signal invari-
ably lead to optimum levels of foreign gene expression was expected to be secreted into the medium; the la-
beled cell supernatants and cell pellet extracts were sep-by HAd5 E3 insertion vectors (Mittal et al., 1995a), the gD
and tgD genes under the control of the SV40 regulatory arately immunoprecipitated with a pool of gD-specific
MAbs and analyzed by SDS–PAGE (Fig. 2). Immunopre-sequences were inserted into the E3 region of the HAd5
genome in the E3 parallel orientation to generate HAd5- cipitation of HAd5-gD-E1 (lane 9)- or HAd5-gD-E3 (lane
13)-infected cell extracts showed a major polypeptidegD-E3 and HAd5-tgD-E3 (Table 1).
band of approximately 71 kDa, similar to the authentic
gD immunoprecipitated from BHV-1-infected MDBK cellReplication kinetics of HAd5 recombinants in
Graham’s 293 and CRLF cells extracts (lane 16), suggesting that gD expressed in
HAd5-gD-E1- or HAd5-gD-E3-infected cells experienced
The growth kinetics of dlE1E3, HAd5-gD-E1, HAd5-tgD- posttranslational modifications similar to the authentic
E1, dlE3, HAd5-gD-E3, or HAd5-tgD-E3 were compared gD. As expected, immunoprecipitation of mock-, dlE1E3-
with those of wt HAd5 in Graham’s 293 cells (HAd5 E1- , or dlE3-infected cell extracts did not produce any signifi-
complementing cell line) as well as in CTRL cells (HAd5 cant protein band. Immunoprecipitation of HAd5-tgD-E1
E1-noncomplementing cell line). The selection of CTRL (lane 8)- or HAd5-tgD-E3 (lane 12)-infected cell superna-
cells as HAd5 E1-noncomplementing cells was due to tants showed a major polypeptide band of approximately
the fact that we chose cotton rats as a small animal 61 kDa. The secretion of tgD into the medium of HAd5-
model to study gD- and HAd5-specific immune re- tgD-E1- or HAd5-tgD-E3-infected cells was very efficient
sponses. The replication kinetics of dlE1E3, dlE3, HAd5-
as only small amounts of tgD were immunoprecipitated
gD-E3, and HAd5-tgD-E3 in Graham’s 293 cells were
from the cell extracts (lanes 7 and 11).
similar to those of wt HAd5, whereas there was an ap-
The above results clearly showed that both E1 and E3
proximately 1- to 2-log decrease in infectious virus titers
insertion vectors containing the gD or tgD gene efficiently
produced by HAd5-gD-E1 and HAd5-tgD-E1 compared
expressed gD or tgD protein in Graham’s 293 cell line,
to wt HAd5 titers (Fig. 1a). The growth characteristics of
supporting replication of both E1 and E3 insertion vec-
dlE3, HAd5-gD-E3, and HAd5-tgD-E3 in CTRL cells were
tors, and that E1 insertion vectors do not grow in a cotton
comparable to those of wt HAd5, whereas as expected
rat cell line, CTRL cells. To determine whether HAd5-gD-for E1 deletion vectors, dlE1E3, HAd5-gD-E1, and HAd5-
E1 or HAd5-tgD-E1 expressed gD or tgD protein, respec-tgD-E1 did not replicate in CTRL cells (Fig. 1b).
tively, in CTRL cells without active virus replication, CTRL
cells infected with either HAd5-gD-E1- or HAd5-tgD-E1Immunoprecipitation of gD or tgD from HAd5
were labeled with [35S]methionine for 4 hr (between 16recombinant-infected cells
and 20 hr postinfection), and the cell extracts or the su-
pernatants, respectively, were individually immunopre-To confirm that HAd5 recombinants containing the
cipitated with a pool of gD-specific MAbs and analyzedBHV-1 gD or tgD gene expressed gD or tgD, respectively,
by SDS–PAGE (Fig. 3). Immunoprecipitation of HAd5-gD-in virus-infected cells, Graham’s 293 cells were infected
E1 (lane 5)-infected cell extracts showed a major poly-with HAd5-gD-E1, HAd5-tgD-E1, HAd5-gD-E3, or HAd5-
peptide band of approximately 71 kDa, similar to thetgD-E3 and were labeled with [35S]methionine for 4 hr
authentic gD (lane 8) immunoprecipitated from BHV-1-(between 16 and 20 hr postinfection). Since the tgD gene
was derived from the gD gene by deleting the sequences infected CTRL cell extracts and recombinant gD (lane 7)
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FIG. 2. Immunoprecipitation of gD or tgD from various HAd5 vectors-
infected Graham’s 293 cell extracts with a pool of gD-specific MAbs.
Mock-, dlE1E3-, HAd5-gD-E1-, HAd5-tgD-E1-, dlE3-, HAd5-gD-E3- or
HAd5-tgD-E3-infected Graham’s 293 cells were labeled with [35S]-
methionine, and the supernatants (lane 1, 3, 5, 7, 9, 11, and 13) and
cell pellets (lane 2, 4, 6, 8, 10, 12, and 14) were immunoprecipitated
with a pool of gD-specific MAbs and analyzed by SDS–PAGE. Mock
(lane 15) and BHV-1 (lane 16)-infected MDBK cell extracts were used
as controls. Since expression of tgD and gD by HAd5-tgD-E1 and HAd5-
gD-E1, respectively, was so efficient, only 10% of the extract was used
in immunoprecipitation for lanes 8 and 9. The gD and tgD are indicated
by arrows. The molecular weight markers are shown on the right. S,
supernatant; P, cell pellet.
comigrated with the HAd5-tgD-E3 (lane 6)-infected cell
supernatant. These results indicate that in HAd5-gD-E1-
or HAd5-tgD-E1-infected CTRL cells, there is expression
of gD and tgD protein, respectively. We did not attempt
to quantitate precisely the gD or tgD expression by HAd5-
gD-E1 or HAd5-tgD-E1, respectively, in CTRL cells com-
pared to that in Graham’s 293 cells.
In order to test the antigenicity of HAd5 recombinants
expressing gD or tgD, HAd5-gD-E1- or HAd5-tgD-E1-in-
fected 293 cells were labeled with [35S]methionine and
the cell extract or the supernatant, respectively, was im-
munoprecipitated with a panel of gD-specific MAbs and
analyzed by SDS–PAGE (Fig. 4). The recombinant gD
and tgD expressed by HAd5-gD-E1 and HAd5-tgD-E1,
respectively, were identified by MAbs which recognize
continuous epitopes (Tikoo et al., 1993b) Ib (MAb 9D6;
FIG. 1. Replication kinetics of replication-incompetent or replication- lanes 1 and 2), IIIa (MAb 10C2; lanes 3 and 4), and IV
competent HAd5 vectors in (a) Graham’s 293 or (b) CTRL cells. Graham’s
(MAb 3D9; lanes 5 and 6). Similarly, both gD and tgD293 or CTRL cell monolayers in 25-mm multiwell culture plates were
were also detected by MAbs which recognize discontinu-infected with wt HAd5, dlE1E3, dlE3, HAd5-gD-E1, HAd5-tgD-E1, HAd5-
ous epitopes (Tikoo et al., 1993b) Ib (MAb 136; lanes 7gD-E3, or HAd5-tgD-E3 at a m.o.i. of 10 PFU per cell. Following incubation
at 377C for 1 hr, virus-infected cell monolayers were washed with PBS, and 8), II (MAb 3E7; lanes 9 and 10), IIIb (MAb 4C1, lanes
and the incubation was continued in maintenance medium containing 2% 11 and 12), IIIc (MAb 2C8; lanes 13 and 14), and IIId
fetal bovine serum. At 6, 12, 24, 36, and 48 hr postinfection, samples were
(MAb 3C1; lanes 15 and 16). Immunoprecipitation of gDcollected and titrated on Graham’s 293 cells by plaque assay.
and tgD expressed by HAd5-gD-E3 and HAd5-tgD-E3,
respectively, in Graham’s 293 cells using MAbs 9D6,immunoprecipitated from HAd5-gD-E3-infected CTRL cell
10C2, 3D9, 136, 3E7, 4C1, 2C8, and 3C1 showed thatextracts. Similarly, immunoprecipitation of the HAd5-tgD-
both proteins are recognized equally well (results notE1 (lane 4)-infected cell supernatant produced a major
protein band of approximately 61 kDa (lane 4), which shown). These results indicate that the antigenicity of
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The presence of gD-specific antibodies in the lung and
nasal washes was also monitored as an indicator of
mucosal immune response. In both the lung and nasal
washes, the gD-specific IgA antibody level was maxi-
mum with HAd5-gD-E1 followed by HAd5-gD-E3,
whereas HAd5-tgD-E1 or HAd5-tgD-E3 failed to raise the
gD-specific IgA antibody level above background (Fig.
6b). Similarly, the gD-specific IgG antibody level was
maximum with HAd5-gD-E1 followed by HAd5-gD-E3,
whereas HAd5-tgD-E1 or HAd5-tgD-E3 failed to raise the
gD-specific IgG antibody level above background (Fig.
6a). In the nasal washes, none of the recombinants in-
duced gD-specific IgG antibody level above background
(Fig. 6a). In the lung and nasal washes, HAd5-specific
IgG and IgA antibody levels were essentially similar in
all recombinant virus-immunized animals after the boost
(Figs. 6c and 6d).
At 3 weeks after primary inoculation, the BHV-1-neu-
FIG. 3. Immunoprecipitation of gD or tgD from various HAd5 vector-
tralizing antibodies were detected only in the sera ofinfected CTRL cell extracts with a pool of gD-specific MAbs. Mock-,
animals immunized with HAd5-gD-E1 and HAd5-gD-E3.dlE1E3-, HAd5-gD-E1-, HAd5-tgD-E1-, dlE3-, HAd5-gD-E3-, or HAd5-
tgD-E3-infected CTRL cells were labeled with [35S]methionine, and the However, following booster immunization, virus-neu-
supernatants (lanes 4 and 6) or cell pellets (lanes 1, 2, 3, 5, and 7) were tralizing titers were maximum with HAd5-gD-E1 followed
immunoprecipitated with a pool of gD-specific MAbs and analyzed by by HAd5-gD-E3, HAd5-tgD-E3, and HAd5-tgD-E1 (Fig. 7a).
SDS –PAGE. The BHV-1-infected CTRL cell extract (lane 8) was used
The HAd5-neutralizing antibody levels in sera of animalsas a control. The gD and tgD are indicated by arrows. The molecular
immunized with E3 insertion vectors were higher than inweight markers are shown on the right.
those of animals immunized with E1 insertion vectors
after secondary inoculation (Fig. 7b).
both recombinant proteins, gD and tgD, is similar to that Spleens were also collected from immunized animals
of the authentic gD produced in BHV-1-infected cells. at 3 weeks after the second immunization to monitor the
gD- and HAd5-specific cell-mediated immune response
Systemic and mucosal immune responses against gD
using lymphocyte proliferation assays. A low level of gD-
and HAd5 in cotton rats immunized with HAd5
specific splenocyte proliferation was detected in animals
recombinants
immunized with HAd5-gD-E1 or HAd5-gD-E3. In contrast,
high levels of HAd5-specific cell proliferation were ob-To determine whether gD and tgD expressed by repli-
served in all recombinant virus-immunized animals (datacation-competent or replication-incompetent HAd5 re-
not shown).combinants could produce immune responses against
both gD and HAd5, cotton rats were inoculated with BHV-1 challenge of cotton rats immunized with HAd5
HAd5 recombinants expressing gD or tgD, initially by recombinants
intradermal inoculation and subsequently by intranasal
Since immunization of cotton rats with various HAd5
inoculation 21 days apart. The serum samples were col-
recombinants expressing gD or tgD results in a gD-spe-
lected at 0, 3, and 6 weeks after primary inoculation
to monitor the development of gD- and HAd5-specific
antibodies by ELISA and virus neutralization assays. Gly-
coprotein gD-specific IgG and IgA serum antibodies
were detected at 3 weeks after primary inoculation and
showed a marked increase after the second inoculation
FIG. 4. Antigenicity of gD and tgD expressed by HAd5 recombinants.(Figs. 5a and 5b). It was interesting to observe that gD-
HAd5-gD-E1 (lanes 1, 3, 5, 7, 9, 11, and 13)- or HAd5-tgD-E1 (lanes 2,specific IgG and IgA antibody levels were maximum with
4, 6, 8, 10, 12, 14, and 16)-infected Graham’s 293 cells were labeled
HAd5-gD-E1 followed closely by HAd5-gD-E3, whereas with [35S]methionine, and cell pellets (lanes 1, 3, 5, 7, 9, 11, and 13) or
HAd5-tgD-E1 as well as HAd5-tgD-E3 produced gD-spe- supernatants (lanes 2, 4, 6, 8, 10, 12, 14, and 16) were immunoprecipi-
tated with a panel of gD-specific MAbs, MAb 9D6 (lanes 1 and 2), MAbcific IgG and IgA antibodies at much reduced levels.
10C2 (lanes 3 and 4), MAb 3D9 (lanes 5 and 6), MAb 136 (lanes 7 andHowever, after secondary immunization HAd5-specific
8), MAb 3E7 (lanes 9 and 10), MAb 4C1 (lanes 11 and 12), MAb 2C8IgG and IgA serum antibody responses were essentially
(lanes 13 and 14), and MAb 3C1 (lanes 15 and 16), and analyzed by
similar in animals inoculated with dlE1E3, dlE3, HAd5- SDS–PAGE. The BHV-1-infected MDBK cell extracts were used as
gD-E1, HAd5-tgD-E1, HAd5-gD-E3, HAd5-tgD-E3 (Figs. 5c controls (not shown). The gD and tgD are indicated by solid and open
arrows, respectively.and 5d).
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FIG. 5. BHV-1 gD-specific and HAd5-specific IgG and IgA responses in sera of cotton rats immunized with HAd5 recombinants expressing gD
or tgD. Cotton rats were inoculated with 107 PFU of dlE1E3, HAd5-gD-E1, HAd5-tgD-E1, dlE3, HAd5-gD-E3, or HAd5-tgD-E3 at Day 0 and Day 21
by intradermal and intranasal routes, respectively. Serum samples were collected at 0, 3, and 6 weeks following primary inoculation and BHV-1
gD-specific (a) IgG and (b) IgA antibodies at a 1:50 dilution of each sample were detected by ELISA. Similarly, HAd5-specific (c) IgG and (d) IgA
antibodies at 1:500 and 1:50 dilutions of each sample, respectively, were also detected by ELISA. Each point represents the mean value for six
animals { SD.
cific immune response, the animals were challenged However, for veterinary vaccines the cost of vaccine pro-
duction needs to be significantly lower than that of vac-with BHV-1 to evaluate the effectiveness of this immune
cines for human use. Since producing subunit vaccinesresponse in protection from infection. Animals were chal-
for use in veterinary medicine using modern biotechnol-lenged with 107 PFU of BHV-1 and the trachea and lungs
ogy approaches is usually very expensive, the develop-were collected at 42 hr postchallenge. Titers of infectious
ment of safe and effective adenovirus-vectored vaccinesBHV-1, recovered from the trachea of animals inoculated
offers an attractive alternative (Berkner, 1992; Grahamwith HAd5-gD-E1 or HAd5-gD-E3, were below the detec-
and Prevec, 1992). To further examine this possibility wetion level. However, animals immunized with HAd5-tgD-
constructed both replication-incompetent and replica-E1 or HAd5-tgD-E3 showed a 1- to 2-log reduction in
tion-competent HAd5 recombinants containing the BHV-virus titers recovered from the trachea compared to
1 gD or tgD gene and tested them in cotton rats with thedlE1E3, dlE3, or PBS controls (Table 2). In addition, there
objective of evaluating their ability to elicit gD- and HAd5-was a more than 2-log decrease in virus titers recovered
specific systemic and mucosal immune responses.from the lungs of cotton rats immunized with HAd5-gD-
Prior to introducing the HAd5 recombinants into ani-E1 or HAd5-gD-E3 and an approximately 1-log reduction
mals, we first characterized their in vitro replication prop-in animals inoculated with HAd5-tgD-E1 or HAd5-tgD-E3
erties. In Graham’s 293 cells, the growth characteristics(Table 2).
of HAd5-gD-E3 and HAd5-tgD-E3 were similar to those
of wt HAd5, dlE3, and dlE1E3; however, infectious virusDISCUSSION
titers of HAd5-gD-E1 and HAd5-tgD-E1 were reduced by
In the past decade significant progress has been made a magnitude of approximately 1 to 2 log. The E1 insertion
in developing more effective vaccines utilizing recombi- vectors and wt HAd5 usually replicate to similar titers in
nant DNA technology. Using these novel approaches a Graham’s 293 cells, unless foreign sequences or their
number of new vaccines have already been licensed gene products are inhibitory to virus replication. We did
not attempt to determine the reason for the lower virusfor use and others are at various stages of registration.
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FIG. 6. BHV-1 gD-specific and HAd5-specific IgG and IgA responses in lung and nasal washes of cotton rats immunized with HAd5 recombinants
expressing gD or tgD. Cotton rats were inoculated with 107 PFU of dlE1E3, HAd5-gD-E1, HAd5-tgD-E1, dlE3, HAd5-gD-E3, or HAd5-tgD-E3 at Day
0 and Day 21 by intradermal and intranasal routes, respectively. The lung and nasal washes were collected at 6 weeks following primary inoculation
and BHV-1 gD-specific (a) IgG and (b) IgA antibodies at a 1:5 dilution of each sample were detected by ELISA. Similarly HAd5-specific (c) IgG and
(d) IgA antibodies at a 1:5 dilution of each sample were also detected by ELISA. Each point represents the mean value for three animals { SD.
titers produced by HAd5-gD-E1 and HAd5-tgD-E1; how- Our results indicate two very significant observations:
(i) the form of antigen produced by the vector can greatlyever, the expression of gD and tgD produced by HAd5-
gD-E1 and HAd5-tgD-E1, respectively, was approxi- influence the immune response and (ii) the replication-
incompetent recombinants (E1 deleted) appear to be ef-mately 10–20 times better than that of gD and tgD pro-
duced by HAd5-gD-E3 and HAd5-tgD-E3, respectively fective vectors for the induction of immunity and therefore
should provide vaccines that are environmentally ex-(data not shown). As anticipated, gD expressed by HAd5-
gD-E1 or HAd5-gD-E3 comigrated with the authentic gD tremely safe. In the case of tgD, the immune response
was clearly reduced compared to the immune response(Tikoo et al., 1993a) expressed in BHV-1-infected cells.
Similarly the HAd5-tgD-E1- or HAd5-tgD-E3-expressed to gD. This was evident regardless of whether the E1
or E3 insertion vectors were employed. Since tgD wastgD was of the expected molecular weight considering
posttranslational modifications and was efficiently se- secreted into the extracellular environment, the reduction
in the gD-specific immune response may be due to fastercreted into the medium. Furthermore, gD and tgD ex-
pressed by HAd5 recombinants were recognized by degradation and/or due to poor recognition of tgD by
antigen-presenting cells compared to the cell mem-MAbs directed against linear and conformational epi-
topes. This suggests that gD and tgD expressed by HAd5 brane-associated gD. These observations are consistent
with other studies using recombinant vaccinia viruses,recombinants undergo posttranslational modifications
similar to those of the authentic gD (Tikoo et al., 1993b). where significant improvement in immunogenicity to an
antigen was achieved by proteins expressed at the cellAll recombinants expressed gD or tgD in Graham’s 293
cells as well as in CTRL cells, indicating that the expres- surface compared to intracellular or secreted forms
(Langford et al., 1986; Andrew et al., 1990; Men et al.,sion of gD and tgD by HAd5-gD-E1 and HAd5-tgD-E1,
respectively, is not dependent on active virus replication. 1991). As suggested by Andrew et al. (1990), the retention
of antigen on the surface of infected cells may facilitateThese results indicate that both replication-competent
and replication-incompetent recombinants should in- the activation of B cells. However, a purified preparation
of recombinant tgD produced in mammalian cells incor-duce immunity in vivo to a magnitude that would protect
animals from infection. porated with an adjuvant when injected into mice (Baca-
AID VY 8044 / 6a1b$$$523 07-16-96 20:27:17 vira AP: Virology
307INDUCTION OF IMMUNE RESPONSES IN COTTON RATS
TABLE 2Estrada et al., 1996) produced a secondary immune re-
sponse similar to that of the authentic gD. This strongly BHV-1 Recovery from Trachea and Lung of Cotton Rats Immunized
suggests that in addition to an effective immunogen, the with HAd5 Recombinants Expressing gD or tgD and Challenged with
BHV-1avaccine formulation, the route of inoculation, and the
presence or absence of adjuvant are important factors
Virus recovery (PFU/g tissue)which may influence the vaccine efficacy and must be
Animal
considered in vaccine architecture. Immunization of cot- group Trachea Lung
ton rats with gD alone results in a very poor (in most of
HAd5-gD-E1 10 1.49 { 1.33 1 104the animals undetectable) immune response (unpub-
HAd5-tgD-E1 1.14 { 0.29 1 105 3.36 { 1.68 1 105lished data). The intention of delivering antigens at the
HAd5-gD-E3 10 1.62 { 1.07 1 104mucosal surface via adenovirus vectors is not merely
HAd5-tgD-E3 7.70 { 2.56 1 104 6.28 { 1.75 1 105
to enhance immunogenicity but also to induce strong dlE1E3 6.57 { 7.80 1 106 4.50 { 2.02 1 106
mucosal immunity to the inserted gene product. dlE3 5.52 { 2.83 1 106 4.11 { 1.91 1 106
PBS 1.38 { 0.10 1 106 4.83 { 1.80 1 106Although HAd5 E1 insertion vectors have been ex-
ploited more to explore their potential as delivery vehi-
a Cotton rats were inoculated with 107 PFU of HAd5-gD-E1, HAd5-cles for human gene therapy (Rosenfeld et al., 1992; Ra-
tgD-E1, HAd5-gD-E3, HAd5-tgD-E3, dlE1E3, or dlE3 at Day 0 and Day
got et al., 1993b; Engelhardt et al., 1994; Yang et al., 23 by intradermal and intranasal routes, respectively. One group was
1995), a few reports suggest their value as virus-vectored similarly inoculated with PBS. At 6 weeks after primary inoculation, the
animals were challenged with 107 PFU of BHV-1, and the trachea andvaccines (Ragot et al., 1993a; Fooks et al., 1995). Both
lung were collected at 42 hr postchallenge for virus isolation. Values
are the mean for three animals { SD.
systemic and mucosal immune responses against gD in
cotton rats immunized with HAd5-gD-E1 were compara-
ble to those of HAd5-gD-E3-inoculated animals. This
clearly demonstrates the usefulness of E1 insertion vec-
tors for producing live replication-incompetent virus vac-
cines. Since E1 insertion vectors do not actively replicate
in human or animals, they should be safer because virus
excretion from vaccinated individuals would not occur.
These vectors may also be useful for vaccinating immu-
nocompromised hosts since they could not spread in
vivo.
In order to test the protective capacity of these vectors
we developed the cotton rat model to compare the vac-
cine potential of various adenovirus-based vaccine can-
didates for BHV-1. Cotton rats vaccinated with HAd5 re-
combinants expressing the hemagglutinin-neuramini-
dase (HN) and fusion (F) protein genes of bovine
parainfluenza virus-3 (BPIV3) were protected from BPIV3
challenge (Breker-Klassen et al., 1995), suggesting the
usefulness of this model in initial vaccination–challenge
trials. Since in a vaccination and challenge trial for BHV-
1 in cattle, virus excretion in the nasal passages and
the clinical score (fever, depression, rhinitis, conjuctivitis,
and loss in body weight) are important parameters for
evaluating the efficacy of a vaccine formulation (van Dru-
FIG. 7. BHV-1- and HAd5-neutralizing antibodies in sera of cotton nen Littel-van den Hurk et al., 1994), we measured the
rats immunized with HAd5 recombinants expressing gD or tgD. Cotton
level of virus excretion in vaccinated animals. The failurerats were inoculated with 107 PFU of dlE1E3, HAd5-gD-E1, HAd5-tgD-
to isolate BHV-1 from the trachea of HAd5-gD-E1- orE1, dlE3, HAd5-gD-E3, or HAd5-tgD-E3 at Day 0 and Day 23 by intrader-
mal and intranasal routes, respectively. The serum samples were col- HAd5-gD-E3-vaccinated cotton rats and the 2-log reduc-
lected at 0, 3, and 6 weeks following primary inoculation were analyzed tion of virus isolation from the lungs following BHV-1
for (a) BHV-1- and (b) HAd5-neutralizing antibodies by virus neutraliza- challenge were considered significant levels of protec-
tion assays. Each point represents the mean value for three animals
tion. Since immunization with recombinants expressing{ SD. Levels of BHV-1- and HAd5-neutralizing antibodies in some
tgD resulted in a significantly lower level of gD-specificgroups were below the detection level (i.e., 1:2 serum dilution), which
are indicated with a value of 1:2 titer for clarity. immune response, it was not surprising that we observed
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Bett, A. J., Prevec, L., and Graham, F. L. (1993). Packaging capacity andmuch higher BHV-1 titers in the trachea and lungs of
stability of human adenovirus type 5 vectors. J. Virol. 67, 5911–5921.animals following BHV-1 challenge compared to those
Braciak, T. A., Mittal, S. K., Graham, F. L., Richards, C. D., and Gauldie,
vaccinated with recombinants expressing gD. J. (1993). Construction of recombinant human type 5 adenoviruses
For the development of an effective vaccine strategy expressing rodent IL-6 genes: An approach to investigate in vivo
cytokine function. J. Immunol. 151, 5145–5153.to protect against mucosal pathogens, such as respira-
Breker-Klassen, M. M., Yoo, D., Mittal, S. K., Sorden, S. D., Haines, D. M.,tory and enteric pathogens, the vaccine delivery that in-
and Babiuk, L. A. (1995). Recombinant adenovirus type 5 expressingduces protective mucosal immunity in the form of secre-
bovine parainfluenza virus type 3 glycoproteins protect Sigmodon
tary IgA antibody is extremely important. Since adenovi- hispidus cotton rats from bovine parainfluenza virus type 3 infection.
rus naturally infects the respiratory and gastrointestinal J. Virol. 69, 4308–4315.
Chanda, P. K., Natuk, R. J., Mason, B. B., Bhat, B. M., Greenberg, L.,tracts of the host, effective mucosal protection against a
Dheer, S. K., Molnar-Kimber, K. L., Mizutani, S., Lubeck, M. D., Davis,number of respiratory and enteric virus pathogens of hu-
A. R., and Hung, P. P. (1990). High level expression of the envelopeman and animals could be induced by appropriately de-
glycoproteins of the human immunodeficiency virus type I in pres-
signed adenovirus vectors. Since immunization with ade- ence of rev gene using helper-independent adenovirus type 7 recom-
novirus vectors will result in in vivo gD expression for binants. Virology 175, 535–547.
Engelhardt, J. F., Ye, X., Doranz, B., and Wilson, J. M. (1994). Ablationmany days similar to a natural BHV-1 infection, it would
of E2A in recombinant adenoviruses improves transgene persistencelikely to lead to a sustained immune response against
and decreases inflammatory response in mouse liver. Proc. Natl.BHV-1. Based on the present encouraging results we
Acad. Sci. USA 91, 6196–6200.
are developing a bovine adenovirus type 3 (BAd3)-based Fehler, F., Herrmann, J. M., Saalmuller, A., Mettenleiter, T. C., and Keil,
expression system for use in cattle. The optimal vaccine G. M. (1992). Glycoprotein IV of bovine herpesvirus expressing cell
line complements and rescues a conditionally lethal viral mutant. J.will presumably be an E1-deleted BAd3 containing the
Virol. 66, 831–839.gD gene, which is more effective than the tgD gene. The
Fooks, A. R., Schadeck, E., Liebert, U. G., Dowsett, A. B., Rima, B. K.,E1-deleted vector is chosen for its safety with minimal
Steward, M., Stephenson, J. R., and Wilkinson, W. G. (1995). High-
loss of efficacy. level expression of the measles virus nucleocapsid protein by using
a replication-deficient adenovirus vector: Induction of an MHC-1-
restricted CTL response and protection in a murine model. VirologyACKNOWLEDGMENTS
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